Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

17.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.8K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

9.9K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.9K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

2.0K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
2.0K
Cross-reactivity00:42

Cross-reactivity

33.7K
Overview
33.7K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

4.0K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
4.0K
T Cell Types and Functions01:24

T Cell Types and Functions

3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus.

Annals of the rheumatic diseases·2026
Same author

Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response.

bioRxiv : the preprint server for biology·2026
Same author

An efficient approach to study ANA⁺ B cells in autoimmune diseases integrating flow cytometry with single-cell analysis.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Six-Month Outcomes in Children With COVID-19 or Multisystem Inflammatory Syndrome in Children.

Hospital pediatrics·2026
Same author

Spatially Distinct Macrophage Subsets Drive Myofibroblast Heterogeneity and Maladaptive Fibrosis in Lupus Nephritis.

bioRxiv : the preprint server for biology·2026
Same author

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression.

Annals of the rheumatic diseases·2026

Related Experiment Video

Updated: Mar 16, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

19.0K

DNA-reactive B cells in lupus.

Jolien Suurmond1, Justine Calise2, Susan Malkiel1

  • 1Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, North Shore-LIJ, 350 Community Drive, Manhasset, NY 11030, USA.

Current Opinion in Immunology
|August 10, 2016
PubMed
Summary

Immune system defects in systemic lupus erythematosus (SLE) allow self-reactive B cells to produce IgG anti-DNA antibodies. Studying genetic factors may reveal patient-specific B cell issues for targeted therapies.

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.6K
Isolation of Double Negative αβ T Cells from the Kidney
06:56

Isolation of Double Negative αβ T Cells from the Kidney

Published on: May 16, 2014

12.9K

Related Experiment Videos

Last Updated: Mar 16, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

19.0K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.6K
Isolation of Double Negative αβ T Cells from the Kidney
06:56

Isolation of Double Negative αβ T Cells from the Kidney

Published on: May 16, 2014

12.9K

Area of Science:

  • Immunology
  • Rheumatology
  • Genetics

Background:

  • Immunoglobulin G (IgG) anti-DNA antibodies are key players in systemic lupus erythematosus (SLE), contributing to both diagnosis and disease pathogenesis.
  • These antibodies promote inflammation via direct tissue binding and Toll-like receptor activation by immune complexes.
  • Their origin is linked to the failure of B cell tolerance mechanisms, leading to the survival and activation of autoreactive B cells.

Purpose of the Study:

  • To explore the heterogeneity of B cell alterations and tolerance defects in SLE patients.
  • To investigate the role of genetic risk alleles in understanding the spectrum of B cell abnormalities in SLE.
  • To identify patient-specific mechanisms underlying IgG anti-DNA antibody production.

Main Methods:

  • Analysis of B cell subsets at various maturation and differentiation stages in SLE patients.
  • Investigation of genetic risk alleles associated with SLE.
  • Correlation of B cell alterations and tolerance failures with IgG anti-DNA antibody production.

Main Results:

  • Systemic lupus erythematosus involves diverse immune perturbations leading to DNA-reactive B cell activation across different B cell subsets.
  • The specific B cells producing IgG anti-DNA antibodies and the nature of tolerance failures vary among SLE patients.
  • Genetic risk alleles are proposed as a key factor in understanding this patient-specific heterogeneity.

Conclusions:

  • Understanding the patient-specific differences in B cell alterations and tolerance mechanisms is crucial for SLE management.
  • This knowledge can facilitate better patient stratification for clinical trials.
  • Identifying these differences may reveal novel therapeutic targets for systemic lupus erythematosus.